-
Health Commission: Newly diagnosed 81 new cases of new crown on the 11th, 61 local cases
Time of Update: 2021-08-26
The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on August 11 The latest situation of the novel coronavirus pneumonia epidemic situation as of 24:00 on A
-
A suspected case of skin anthrax in Wenshui, Shanxi has been treated in isolation
Time of Update: 2021-08-26
At present, the local area has isolated and treated 5 cases in Wenshui County, disinfected their place of activity and excrement, conducted investigation and control of contacts, carried out active case searches in Baoxian Village, and asked village doctors to strengthen surveillance.
-
The State Food and Drug Administration issued a notice that 18 batches of drugs did not meet the requirements
Time of Update: 2021-08-26
After inspection by Hubei Provincial Institute of Drug Supervision and Inspection, a batch of Atractylodes japonicus (fried atractylodes with bran) produced by Anhui Wukeng Chinese Medicine Decoction Pieces Co.
-
National Health Commission: 13 new local confirmed cases on the 15th
Time of Update: 2021-08-26
The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on August 15 The latest situation of the novel coronavirus pneumonia as of 24:00 on August 15 The latest
-
The lambda strain swept South America, here is what you want to know
Time of Update: 2021-08-26
The Australian "Dialogue" magazine reported that preliminary research data on lambda showed that lambda is more contagious, and it is more likely to infect human cells than the original new coronavirus and variants of alpha and gamma .
-
Why does the delta mutant strain spread so fast?
Time of Update: 2021-08-26
Shanghai epidemic prevention and control leading group members of the Group of Fudan University Shanghai Medical College, Vice President Wu Fan: Although the vaccine is not hundred percent block the infection, but it can effectively reduce the proportion of severe, this point is very important .
-
The highest rate of decrease was 71.30%, and the prices of 591 consumables such as Medtronic and Dabo were reduced
Time of Update: 2021-08-26
On August 16, the Liaoning Provincial Drug and Medical Consumables Centralized Purchasing Network issued the "Notice on the Result of Active Price Reduction of 122 Consumables Including Drug Eluting
-
28 new confirmed cases were confirmed on August 17 and 6 local cases were in Jiangsu
Time of Update: 2021-08-26
The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on August 17 The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on August 17 T
-
The standard for pharmaceutical packaging materials is about to be listed in the Chinese Pharmacopoeia!
Time of Update: 2021-08-26
Yang Zhaopeng, Deputy Secretary-General of the Commission emphasized that our Commission should accelerate the development of the "Chinese Pharmacopoeia" standard system for pharmaceutical packaging materials.
Yang Zhaopeng, deputy secretary-general of the Pharmacopoeia Commission, emphasized that the Commission should accelerate the construction of the "Chinese Pharmacopoeia" standard system for pharmaceutical packaging materials.
-
The 2020 drug review report is released!
Time of Update: 2021-08-17
The Center for Drug Evaluation has completed 8606 registration applications requiring technical review, and 1561 new drug clinical trial (IND) applications have been reviewed, an increase of 55.
-
Puli Pharmaceuticals: Levetiracetam concentrated solution for injection has been approved for marketing in Thailand
Time of Update: 2021-08-17
On June 21, Puli Pharmaceuticals announced that the concentrated solution of levetiracetam for injection has been approved by the Food and Drug Administration of Thailand . Levetiracetam injection co
-
The licensed pharmacist supervision app is here
Time of Update: 2021-08-17
According to Jingdezhen's online news, in September 2020, Jingdezhen City launched a pilot program for a licensed pharmacist management system, which integrates various functions such as continuing education, academic qualification improvement, and market supervision, and can implement GPS positioning and face recognition attendance for pharmacists .
-
Subcutaneous injection of PD-L1 antibody envolimab was again approved as an orphan drug by the U.S. FDA
Time of Update: 2021-08-16
Corning Jereh announced that the company's self-developed recombinant humanized PD-L1 single domain antibody envolimab injection has been granted orphan drug designation by the US Food and Drug Administration for the treatment of soft tissue sarcoma .
-
Takeda is sued for delaying the listing of Amitiza's generic drug
Time of Update: 2021-08-16
CompilationFan DongdongA few days ago, foreign media reported that according to the latest class-action lawsuit, the patent agreement reached between Takeda and Endo’s Par Pharmaceuticals delayed the launch of Takeda’s constipation drug Amitiza, suspected of violating the antitrust law, causing The patient's medical expenses exceeded hundreds of millions of yuan .
-
Qianjin Pharmaceutical Co., Ltd. Valsartan tablets obtained drug registration certificate and regarded as over-evaluated
Time of Update: 2021-08-16
On the 24th, Qianjin Pharmaceutical announced that its subsidiary Qianjin Xiangjiang Pharmaceutical received the "Drug Registration Certificate" for valsartan tablets approved by the State Food and Drug Administration.
Valsartan tablets are an angiotensin II receptor blocker developed by Novartis, Switzerland, and are mainly used for mild to moderate essential hypertension .
-
Jianyou shares: Daptomycin for injection has been approved by the US FDA for drug registration
Time of Update: 2021-08-16
On June 30, Jianyou shares announced that its subsidiary Hong Kong Jianyou recently received daptomycin for injection, 500mg/bottle (ANDA number: 213623), 350mg/bottle (ANDA number: 213786) issued by the US Food and Drug Administration.
Letter of approval .
-
Reached the main clinical endpoint!
Time of Update: 2021-08-16
Note: The original text has been deletedReference materials:[1] Jun Shengtai will present the results of the Phase II clinical trial of HTD1801 in the treatment of primary sclerosing cholangitis.
-
A giant pharmacy store will break 10,000
Time of Update: 2021-08-16
In 2020, the common people's pharmacy told the media that in the next three years, the company will maintain a growth rate of about 2,000 new stores each year, including directly-operated stores, franchised stores, and mergers and acquisitions stores .
-
U.S. biosimilar drugs may welcome ten years of continuous growth
Time of Update: 2021-08-16
. "Ronny Gal, an analyst at Bernstein in the United States, said in a quarterly study on the performance and prospects of biosimilars, "Although it may not be obvious on the surface, biosimilars have always been the main force in easing drug prices .
-
Haichen Pharmaceutical's Entecavir Tablets Obtained Drug Registration Approval
Time of Update: 2021-08-16
On the 28th, Haichen Pharmaceutical announced that the company’s entecavir tablets had recently received the "Drug Registration Certificate" approved and issued by the State Drug Administration .
Entecavir tablets are a guanosine analogue, which has an inhibitory effect on hepatitis B virus (HBV) polymerase .
